Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
Young breast cancer survivors could safely temporarily stop adjuvant endocrine therapy (ET) to attempt pregnancy, according to primary results of the POSITIVE* trial presented at SABCS 2022.
Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
05 Jan 2023Postoperative neutropaenia tied to early CRBSI in children with leukaemia
Paediatric patients with acute myeloid leukaemia and other leukaemias (AML/OLs), especially those with persistent neutropaenia during the first 30 postoperative days, are at increased risk of early catheter-related bloodstream infections (CRBSIs), according to a Singapore study.
Postoperative neutropaenia tied to early CRBSI in children with leukaemia
05 Jan 2023SG kids prone to multisystem inflammatory syndrome amid high COVID-19 transmission
Children in Singapore are at risk of developing multisystem inflammatory syndrome (MIS-C), especially due to the increased community transmission of COVID-19 in 2021, according to a study. MIS-C incidence may also intensify with the arrival of new variants of concern (VOCs) and relaxation of pandemic restrictions.
SG kids prone to multisystem inflammatory syndrome amid high COVID-19 transmission
04 Jan 2023Edoxaban prevents thromboembolism in children with cardiac disease
Edoxaban may be used as an alternative treatment for thromboembolism (TE) prevention in children with cardiac disease showing low rates of clinically relevant bleeding and TE, suggests a study. Some of its advantages include once-daily dosing and infrequent monitoring requirement.
Edoxaban prevents thromboembolism in children with cardiac disease
04 Jan 2023Parkinson’s, T2D drug affords cardioprotection in youth with T1D
Bromocriptine quick release, a medication used for Parkinson’s disease and type 2 diabetes (T2D), appears to confer cardiovascular benefits such as lower blood pressure (BP) and reduced aortic stiffness in teenagers with type 1 diabetes (T1D), according to data from the BCQR-T1D study.
Parkinson’s, T2D drug affords cardioprotection in youth with T1D
31 Dec 2022Semaglutide triumphs as an anti-obesity treatment for adolescents
Adding a once-weekly dose of semaglutide to lifestyle intervention successfully reduced body mass index (BMI) in adolescents with obesity, according to results of the phase IIIa STEP TEENS trial.